TP53 and cancer: In summary, our cancer phenotype characterization and integrated analysis at the molecular level demonstrate heterogeneous cellular phenotypes induced by different p53 missense mutant proteins that can be attributed in part to the mutant-specific changes in downstream target gene expression via both direct and indirect regulatory mechanisms by altered DNA binding capability and preference.